When investigating several potential prognostic parameters in UCB, Hilmy et al. concluded that systemic factors of the inflammatory response such as levels of C-reactive protein were superior to tumor-based factors such as grade, COX2 expression or T-lymphocytic infiltration [18]. This evidence concerns the gene PTGS2 and neoplasm.